KVU-21616-72316
1 vaccination
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 675 / KS
- Registered
- 2021-01-05
- Relationship
- Self
Timeline
-
2020-12-21
Dose 1 — Pfizer-BioNTech
-
2021-01-05
Registered in v-safe
-
2021-01-05
Survey response — day 14, dose 1MedDRA: Ageusia, Anosmia, Headache, Pain, Pyrexia — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesFree text: Lost taste and smellFeverBody achesHeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-05
Report sent to call center — day 14, dose 1Be unable to work · Be unable to do your normal daily activities1 call case(s)
- 2021-01-10
- 2021-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-21 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — day 14, dose 1
Symptoms: Lost taste and smellFeverBody achesHeadache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Ageusia | ✓ | ✓ | ✓ |
| SD | Anosmia | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pyrexia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release